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Abstract
Background: Allergen induced early phase airway response and airway plasma exudation are predominantly
mediated by inflammatory mast cell mediators including histamine, cysteinyl leukotrienes (cysLTs) and
thromboxane A2 (TXA2). The aim of the present study was to evaluate whether repeated allergen exposure affects
early phase airway response to allergen challenge.
Methods: A trimellitic anhydride (TMA) sensitized guinea pig model was used to investigate the effects of low
dose repeated allergen exposure on cholinergic airway responsiveness, early phase airway response and plasma
exudation, as well as local airway production of mast cell derived cysteinyl leukotrienes and thromboxane B2
(TXB2) after allergen challenge.
Results: Repeated low dose allergen exposure increased cholinergic airway responsiveness. In contrast, early phase
airway response and plasma exudation in response to a high-dose allergen challenge were strongly attenuated
after repeated low dose allergen exposure. Inhibition of the airway response was unspecific to exposed allergen
and independent of histamine receptor blocking. Furthermore, a significant reduction of cysteinyl leukotrienes and
TXB2 was found in the airways of animals repeatedly exposed to a low dose allergen. However, in vitro stimulation
of airway tissue from animals repeatedly exposed to a low dose allergen with arachidonic acid and calcium
ionophore (A23187) induced production of cysteinyl leukotrienes and TXB2, suggesting enhanced activity of
5-lipoxygenase and cyclooxygenase pathways.
Conclusions: The inhibition of the early phase airway response, cysteinyl leukotriene and TXB2 production after
repeated allergen exposure may result from unresponsive effector cells.
Keywords: Guinea pig, Allergen exposure, Cholinergic responsiveness, Early phase airway response, Plasma exuda-
tion, 5-lipoxygenase, Cyclooxygenase
Introduction
Early phase airway response to allergen and airway plasma
exudation are predominantlym e d i a t e db yi n f l a m m a t o r y
mediators including histamine, cysteinyl leukotrienes
(cysLTs) and thromboxane A2 (TXA2) [1-3] released from
mast cells in the response to allergen challenge [4-7]. In
asthmatic patients, the concentrations of cysLTs and
TXA2 are increased in plasma, urine and BAL fluid during
asthma exacerbation and after experimental allergen chal-
lenges [8-11]. Thus, these mediators can induce both air-
way constriction and airway plasma exudation in several
species [3,12-14]. Production of these mediators needs the
substrate arachidonic acid and enzymes such as 5-lipoxy-
genase (5-LO) and cyclooxygenase (COX) [15]. Further-
more, mast cell responsiveness involve expression and
binding of allergen to the high affinity IgE-receptor
(FcεRI) and subsequent activation of intracellular signaling
molecules activating the 5-LO and COX pathway [16-19].
Repeated or chronic exposure to low doses of allergen,
such as house-dust mite, animal dander, or some occu-
pational allergen is quite common in real life. Evidence
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gest that repeated allergen exposure may induce non-
specific bronchial hyperresponsiveness (BHR) and airway
inflammation [20-22]. However, the effect of repeated
exposure to allergen on the early phase airway response
however is not clear. Thus, in the current study, we
hypothesize that repeated allergen exposure may reduce
early phase airway response, since patients allergic to cat
repeatedly exposed to low doses of cat allergen prior to
high dose allergen challenge, displayed a attenuated late
phase response despite existing bronchial hyperrespon-
siveness [23]. Therefore, the aim of the present study
was to evaluate whether repeated exposure to allergen
affects early phase airway response to allergen and
further elucidate the possible mechanisms. Thus, in the
present study, we utilized a trimellitic anhydride (TMA)
sensitized guinea pig model. TMA is an occupational
small molecular allergen widely encountered in plastic
industry. Furthermore, it is known that skin contact and
inhalation of TMA can stimulate the immune system
and thus induce asthma in humans [24]. In the present
study, we repeatedly exposed sensitized guinea pigs to
allergen (TMA), prior to the high dose challenge and
evaluated cholinergic bronchial responsiveness and spe-
cific early phase airway responses to allergen. We also
tested the possible mechanisms behind the changes of
early phase airway response, including the levels of
cysLTs and TXB2 in airway, activity of 5-LO and COX
pathways, as well as the activity of protein tyrosine
kinase Lyn, one of intracellular signaling molecules
downstream FcεRI.
Materials and methods
Allergen sensitization and exposure
Male Dunkin Hartley guinea pigs (initial weight 200-250 g)
were obtained from HB Sahlins Försöksdjurfarm, Malmö,
Sweden. Guinea pigs were sensitized by intradermal injec-
tion of a suspension of 3, 1, and 0.1 mg of TMA in 0.1 ml
corn oil on day 1, 10 and 20, respectively (Figure 1). Intra-
dermal injection (i.d.) of corn oil was used as control sub-
stance in non-sensitized animals. In double sensitization
experiments, animals were sensitized as above but also
administered 0.3 mg ovalbumin in 0.1 ml PBS i.d. On day
30 to 34, animals were exposed to an aerosol of TMA con-
jugated to guinea pig serum albumin (TMA-GPSA).
Guinea pigs were exposed either to a high dose (0.15%
TMA-GPSA) once for 15 min (day 34), or to low doses
(0.03% TMA-GPSA) for 15 min each day on 5 consecutive
days (day 30-34), in a Plexiglas chamber (Figure 1). Aero-
sol of the vehicle (PBS) was used as control. The aerosols
were generated by a compressed air jet nebulizer (Maxin
MA2, Clinova Medical AB, Malmö, Sweden; mean mass
diameter < 3 μm in water). Pyrilamine (10 mg/kg, i.p.) was
used 30 min before aerosol exposure to block the effects
of histamine to minimize the potential fatal airway
responses. This study was approved by the animal ethics
committee in Göteborg. Dnr 88/98.
Study design
Animals were divided into four groups (7-12 in each
group). Group 1 was not sensitized (i.d. corn oil), and
was sham-exposed to PBS on 5 consecutive days. Group
2, 3, and 4 were sensitized to TMA. Group 2 was exposed
to PBS on 5 consecutive days; group 3 was exposed to
PBS on 4 consecutive days, followed by a single high dose
of TMA-GPSA (0.15%) exposure; group 4 was exposed to
low dose of TMA-GPSA (0.03%) on 5 consecutive days.
The total dose of allergen received by animals of group 3
and 4 was exactly the same. ACh responsiveness was
evaluated 24 hours after the last exposure. The early air-
way response to TMA-GPSA was measured one hour
after the completion of the ACh responsiveness. BAL
fluid was taken after the early airway response measure-
ment, for evaluation of inflammatory cells and levels of
LTC4/D4/E4, TXB2 and PGE2 (Figure 1).
Cholinergic airway responsiveness
Anaesthetized and ventilated guinea pigs were provoked
with inhaled aerosol of acetylcholine (ACh) (1 × 10
-5,3×
10
-5,1×1 0
-4 and 3 × 10
-4 M; 10 ml/kg for 20 inhala-
tions) at a 10-min interval until RL increased at least
500% above the baseline. Aerosol was generated by an
ultrasonic nebulizer (Pulmo-Sonic Model 2511, The
DeVilbiss Co., Somerset, PA, U.S.A.) and driven by a ven-
tilator. Lung resistance (RL) was measured as previously
described [22] immediately after each ACh provocation
for 10 min. A dose-response curve was constructed, and
cholinergic airway responsiveness was expressed as pro-
vocative concentration of ACh, which increased RL 500%
above the baseline (-Log PC500). Ten minutes before
ACh provocation, animals were pretreated with pyrila-
mine (5 mg/kg, i.v.), propranolol (1 mg/kg, i.v), and suxa-
methonium 5 mg i.v.).
Early phase airway response to allergen
One hour after the completion of ACh assessment, ani-
mals were challenged with intratracheal instillation of
250 μgT M A - G P S Ai n5 0μlP B S .L u n gr e s i s t a n c ew a s
measured for 10 min. The immediate airway response
was expressed as area under the curve (AUC) of RL from
0 to 10 minutes for statistical analysis.
Specificity of early phase airway response to exposed
allergen
To evaluate the specificity of early phase airway response
to exposed allergen, we sensitized animals of three groups
(7 in each group) with both TMA and OVA. Group 1 was
exposed to PBS, group 2 to 0.03% TMA-GPSA, and group
3 to 0.03% OVA on five consecutive days. Early phase
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challenge were evaluated 24 hours after the last exposure.
Analysis of Evans blue dye exudation
Evans Blue dye (20 mg/kg) was injected i.v. over one
minute, two minutes before allergen challenge. Animals
were sacrificed by an over-dose of anaesthesia after the
assessment of airway obstruction. The thoracic cavity
was opened and systemic and pulmonary circulation was
perfused with 100 ml PBS, respectively. The trachea,
main bronchi, proximal intrapulmonary airways (PIA),
distal intrapulmonary airways (DIA) was assessed. All tis-
sues were freeze dried (MicroModulyo, Edwards High
Vacuum International, West Sussex, U.K.) for 24 hours
and then weighted. Evans Blue dye was extracted in 2 ml
formamide in a 37°C water bath for 16 hours. Absorption
of extracted Evans Blue dye at 620 nm was measured
with a spectrophotometer (PU 8670 VIS/NIR, Philips,
Norden, Stockholm, Sweden). The concentration of
Evans Blue dye was quantified by interpolation on a stan-
dard curve and expressed as ng dye/mg dry tissue. The
Evans Blue dye measurement has previously been shown
to highly correlate with the exudation of radio labeled
albumin in guinea pig airways [25].
Effects of LT1 receptor and COX on early phase airway
response
Three groups of guinea pigs (8-11 in each group) were
sensitized with TMA. Ten days after sensitization, we
evaluated the roles of LT1 receptor and COX on the
early phase airway response and plasma exudation to
TMA-GPSA challenge by applying ICI 198,615 (a LT1
receptor antagonist) and indomethacin (a non-specific
COX-inhibitor). In this experiment, animals of group 1
were pretreated with the vehicle for ICI 198,615 and the
vehicle for indomethacin 10 minutes before TMA-GPSA
challenge. Group 2 received ICI 198,615 (10
-6 mol/kg, i.
v.) and the vehicle for indomethacin, and group 3
received ICI 198,615 (10
-6 mol/kg, i.v.) and indomethacin
(10 mg/kg, i.v.). All animals were injected with Evans
blue dye, two minutes before the intratracheal instillation
of TMA-GPSA. The early phase airway response and
Evans blue dye exudation were evaluated [25].
Inflammatory cells in BAL fluid
After the assessment of early phase airway response,
animals were immediately sacrificed by over-dose of
anaesthesia and the bronchial alveolar lavage (BAL)
fluid was taken. For performing this, the thoracic cavity
was opened. The systemic and pulmonary circulation
were perfused through the left ventricle and the pul-
monary artery with 100 ml PBS without Ca2+ and Mg2
+, pH7.4, at room temperature to remove blood in the
circulation. The airways were lavaged through the tra-
cheal cannula by gentle instillation and aspiration of
sterile PBS 4 ml for 5 times at room temperature. One
ml BAL fluid was centrifuged at 3000 rpm at 4°C for
10 min, supernatant was collected and kept at -80°C
until LTC4/D4/E4, TXB2, and PGE2 analysis. Total
cell number in BAL fluid was determined in a haemo-
cytometer using Türks solution. Cytocentrifuged pre-
parations were stained with Giemsa and differential cell
counts were carried out on 300 cells according to stan-
dard morphologic criteria.
Allergenand/orPBS
exposure
Allergen
challenge ACh BAL Sensitization
Day1,10and20 Day30Ͳ34 Day35
TimeͲlineofexperiments
Figure 1 Experimental design. Briefly, animals were sensitized by intradermal injection of a suspension of 3, 1, and 0.1 mg of TMA in 0.1 ml
corn oil on day 1, 10 and 20, respectively. In double sensitization experiments, animals were sensitized as above but also administered 0.3 mg
ovalbumin in 0.1 ml PBS by intradermal injection. Animals were exposed to an aerosol of PBS or TMA conjugated to guinea pig serum albumin
(TMA-GPSA) on day 30 to 34. One group of animals was exposed to PBS on day 30-33 followed by a high dose TMA-GPSA (0.15%) exposure
once for 15 min on day 34. One group of animals was exposed to a low dose TMA-GPSA (0.03%) for 15 min each day on 5 consecutive days.
ACh responsiveness was evaluated 24 hours after the last exposure. The early airway response to TMA-GPSA was measured one hour after the
completion of the ACh responsiveness (some changes were made on day 35 for other experiments, see study design/protocol section).
Bronchial alveolar lavage (BAL) fluid was taken immediately after the assessment of early airway response.
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LTC4/D4/E4, TXB2 and PGE2 in BAL fluid and airway
tissue culture medium were measured with commercial
enzyme immunoassay (EIA) kits (Cayman Chemical Com-
pany, MI, USA) according to the manufacturer’s instruc-
tions. The concentrations of LTC4/D4/E4, TXB2 and
PGE2 in BAL fluid are expressed as pg/ml BAL fluid. The
productions of LTC4/D4/E4 and TXB2 in the airway tis-
sue in vitro are dependent on the size of the airway tissue
and incubation time. To standardize the measurement, the
production of LTC4/D4/E4, TXB2 was therefore
expressed as pg/mg protein of the airway tissue/min of
incubation time. The volume of protein in the airway tis-
sue was measured with the Bio-Rad DC Protein Assay
(Bio-Rad Laboratories, CA, USA).
Capacity of airway to produce cysLTs and TXB2
Animals of two groups (8 in each group) were sensitized
with TMA. One group was exposed to PBS and one group
was exposed to 0.03% TMA-GPSA on five consecutive
days. Animals were sacrificed by over-dose of anaesthesia
twenty-four hours after the last exposure, The thoracic
cavity was opened, pulmonary and systemic circulations
were perfused with PBS. Trachea, main bronchi, and intra-
pulmonary airways were dissected from each other and
each portion was cut into 10 aliquots respectively. The air-
w a yt i s s u em i x t u r e sw e r em a d eb yr a n d o m l yt a k i n go n e
aliquot from each portion. After equilibration by incuba-
tion in 1 ml culture medium (Waymouth MB 752/1) at
37°C for 2 hours, airway tissue was washed by removing
the medium and replacing it with 1 ml fresh medium for
four times. The tissue was then incubated for additional
15 min in 1 ml fresh medium complemented with either
(1) 10 μl of the vehicle for calcium ionophore (DMSO,
final concentration 0.2%) and 10 μl of the vehicle for ara-
chidonic acid (AA) (95% ethanol); (2) 10 μl calcium iono-
phore (A23187) (final concentration 30 μM) and 10 μlo f
the vehicle for arachidonic acid (AA); and (3) 10 μlA A
(final concentration is 10, 30, 100 μM) and 10 μlo ft h e
vehicle for A23187. The culture medium and airway tissue
were collected and kept at -80°C until analysis of LTC4/
D4/E4 and TXB2.
Activity of protein tyrosine kinase Lyn after repeated
allergen exposure
Animals of two groups (10 in each group) were sensitized
with TMA. Group 1 was exposed to PBS and group 2 to
0.03% TMA-GPSA on five consecutive days. Twenty-four
hours after the last exposure, we isolated the airway tissues
and measured the activity of enzyme protein tyrosine
kinase Lyn in the airway tissues with ELISA. Activity of
protein tyrosine kinase lyn in the homogenate of the airway
tissue was measured with a commercial ELISA kit (Pierce,
Rockford, IL, USA) according to the manufacturer’s
instructions. The production of phosphopeptides in the tis-
sue homogenate is dependent on the activity and amount
of the protein tyrosine kinase as well as incubation time.
To standardize the measurement, the activity of protein
tyrosine kinase Lyn was therefore expressed as pg phos-
phopeptides/mg protein of tissue homogenate/min of incu-
bation time.
Drugs and chemicals
The following drugs and chemicals were used: ketamine
hydrochloride (Park-Davis S.A., Barcelona, Spain); xylazine
chloride (Bayer Sverige AB, Göteborg, Sweden); suxa-
methonium chloride (KabiVitum AB, Stockholm, Sweden);
propranolol, pyrilamine, acetylcholine, corn oil, Way-
mouth MB 752/1 medium, calcium ionophore (A23187),
DMSO, arachidonic acid and ovalbumin (Sigma-Aldrich
Chemical Co., St Louis, USA); ICI 198,615 (Zeneca AB
Sweden); indomethacin (A/S Dumex, Danmark); trimellitic
anhydride (Sigma-Aldrich) and TMA-GPSA conjugate
(Dept. of Occupational and Environmental Medicine,
Lund University Hospital, Sweden).
Data and statistical analysis
Data are expressed as mean ± S.E.M. for each group.
Mann-Whitney U-test was used to test statistical signifi-
cance of difference between two groups. If three or more
groups were involved, Kruskal-Wallis test was used at
first to ascertain that significant variance exists among
the groups studied. A p-value less than 0.05 was consid-
ered significant.
Results
Inflammatory cells in BAL fluid
The percentage of eosinophils was significantly higher in
all sensitized animals compared to non-sensitized ani-
mals. Among the sensitized animals, a single dose aller-
gen (0.15% TMA-GPSA) exposure enhanced the
percentage of eosinophils compared to PBS exposure.
By contrast, the percentage of eosinophils in BAL fluid
was significantly lower after repeated exposure to aller-
gen (0.03% TMA-GPSA on five consecutive days), com-
p a r e dt os i n g l ee x p o s u r e( T a b l e1 ) .T h ep e r c e n t a g eo f
macrophages was significantly lower in all sensitized
compared to non-sensitized animals, whereas the per-
centage of lymphocytes in sensitized and PBS exposed
animals was higher than that in non-sensitized animals.
There was no significant difference in neutrophil per-
centage between the treatment groups (Table 1).
Cholinergic airway responsiveness
Repeated exposure of allergen (0.03% TMA-GPSA on five
consecutive days) significantly enhanced cholinergic
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(Figure 2). There were no significant differences in base-
line RL among the groups.
Early phase airway response
In non-sensitized animals, no early phase airway
response was induced by intratracheal instillation of
T M A - G P S A .I ns e n s i t i z e da n i m a l s ,ap r o n o u n c e d
immediate airway response to TMA-GPSA was seen in
animals previously exposed to PBS or to a single dose of
allergen (0.15% TMA-GPSA). However, repeated expo-
sure of allergen (0.03% TMA-GPSA on five consecutive
days) strongly inhibited the immediate airway response
to TMA-GPSA (Figure 3B).
Specificity of early phase airway response to exposed
allergen
Repeated exposure to either TMA-GPSA or OVA signifi-
cantly down-regulated early phase airway response and
Evans blue dye exudation to OVA in double sensitized ani-
m a l s( T M Aa n dO V A )( F i g u r e4 A ,Ba n d4 C ,r e s p e c t i v e l y ) .
Effects of LT1 receptor and COX on early phase airway
response
Combined treatment with ICI 198,615 (LT1 receptor
antagonist) and indomethacin (COX inhibitor) signifi-
cantly inhibited early phase airway response induced by
intratracheal challenge of TMA-GPSA in sensitized ani-
mals (Figure 5A). ICI 198,615 alone or in combination
Table 1 Cell composition in BAL
Total cells (× 10
6/lung) Macro (%) Eos (%) Neutro (%) Lympho (%)
Non-sen, PBS-expo 5.9 ± 0.9 79.1 ± 2.0 15.1 ± 1.4 4.0 ± 0.7 1.8 ± 0.3
Sen, PBS-expo 2.8 ± 0.8 57.2 ± 4.9* 31.1 ± 3.7* 7.6 ± 1.4 4.0 ± 0.6
Sen, single TMA-expo 4.3 ± 0.9 43.6 ± 3.9* 46.4 ± 3.3*# 6.9 ± 2.0 3.1 ± 0.5
Sen, repeated TMA-expo 6.3 ± 0.6 64.7 ± 3.5* 26.7 ± 2.4*§ 6.0 ± 1.7 2.6 ± 0.3
The number of cells in BAL fluid in non-sensitized, PBS-exposed, sensitized PBS-exposed sensitized single TMA-exposed and sensitized repeated TMA-exposed
groups. Data are expressed as mean ± SEM, Mann-Whitney U test, n = 11-16. *p < 0.05 non-sensitized, PBS-exposed group versus sensitized groups. # p < 0.05
sensitized, PBS-exposed group versus sensitized, single TMA-exposed group. §p < 0.05 sensitized, repeated TMA-exposed versus single TMA-exposed group.
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exudation in all airway levels (Figure 5B).
Levels of LTC4/D4/E4, TXB2 and PGE2 in BAL fluid and
airway tissue
Repeated exposure to allergen on five consecutive days
(0.03% TMA-GPSA) significantly reduced the levels of
LTC4/D4/E4 and TXB2 in BAL fluid in a response to a
high dose of allergen challenge (Figure 6). There was a
tendency of reduction of level of PGE2 in BAL fluid
after repeated allergen exposure (Figure 6).
A high concentration of calcium ionophore (A23187,
30 μM) significantly increased LTC4/D4/E4 production
in airway tissues in vitro, but there was no significant
difference between repeated exposure to PBS and TMA-
GPSA (0.70 ± 0.18 and 0.64 ± 0.12 pg/mg protein/min
respectively; n = 6 in each group).
Arachidonic acid (AA) dose-dependently caused pro-
duction of LTC4/D4/E4 and TXB2 in the airway tissues
in vitro. Repeated TMA-GPSA exposure significantly
enhanced the levels of LTC4/D4/E4 and TXB2 com-
pared to corresponding PBS exposure (Figure 7).
Activity of the protein tyrosine kinase Lyn
There was no differences in activity of the protein tyro-
sine kinase Lyn (both cytosolic and membrane bound)
in airway tissue between allergen or PBS exposure on
five consecutive days (cytosolic: 1.63 ± 0.1 vs 1.57 ±
0.18; cytosolic: 1.88 ± 0.1 vs 1.63 ± 0.17 pg phosphopep-
tide/mg protein/min, n = 10 in each group).
Discussion
In the present study, we have confirmed our previous
findings that repeated allergen exposure increases airway
cholinergic responsiveness [22]. However, we further
found that repeated allergen exposure attenuates the
early phase airway response to allergen and the produc-
tion of LTC4/D4/E4 and TXB2 in airway during the
early phase airway response.
Airway eosinophilia and bronchial hyperresponsive-
ness are important characteristics of allergic asthma
[26]. The present study shows that sensitization alone
increases the number of eosinophils in BAL fluid of gui-
nea pigs, and that a single high dose allergen exposure
(0.15%TMA-GPSA) further increases this number.
Repeated exposure to allergen (0.03%TMA-GPSA on
five consecutive days) does not however, significantly
increase airway eosinophils compared with PBS-expo-
sure, despite a significantly enhanced cholinergic airway
responsiveness. This is in line with a previous study in
Brown Norway rats showing that airway epithelial
damage and bronchial hyperresponsiveness are induced
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evident airway eosinophilia [22]. Thus, our experiments,
together with other studies, suggest that bronchial
hyperresponsiveness is not always dependent on an
ongoing eosinophilic inflammation [22,27-29].
Sensitized guinea pigs, exposed to either PBS or single
dose of TMA-GPSA, presented an early phase airway
response to allergen. This airway response however was
almost totally eliminated by repeated exposures to low
doses of allergen. This reduced airway response is not
due to a general reduction of contractility of the airway
smooth muscle, since ACh responsiveness was higher
after repeated allergen exposure (Figure 2). Furthermore,
this is not either due to an increased release of endogen-
ous bronchodilating substances since production of
PGE2 also showed a tendency of decrease after repeated
allergen exposure. Thus, the reduced early phase airway
response, however strongly suggests a reduced mast cell
responsiveness after repeated allergen exposure. Mast
cell responsiveness involves the expression of the high
affinity receptor for IgE (FcεRI) as well as binding of IgE
receptor on the cell surface and interaction of allergen
and a subsequent production and release of mediators
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Figure 5 Immediate airflow obstruction (A) and Evans blue dye (EBD) exudation (B) after intratracheal instillation of TMA-GPSA in
sensitized guinea pigs treated with vehicle, ICI 198,615 or the combination of ICI 198,615 and indomethacin. Data are expressed as
mean ± SEM, Mann-Whitney U test, *p < 0.05, **p < 0.01, n = 8-11 in each group.
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Page 8 of 11histamine, cysLTs, and probably also TXA2 released
from mast cells during the response to allergen challenge.
These mediators can induce both airway constriction and
airway plasma exudation [3,12,14].
To further delineate if the reduced response to TMA
challenge seen in the repeatedly exposed animals is due
to a tolarized effect to the TMA-GPSA allergen. We
sensitized guinea pigs with two allergens (TMA and
OVA), and exposed animals to one of the two allergens
and thus evaluated the early phase airway response and
plasma exudation. Our experiment revealed that
repeated exposure to each of allergens (either TMA-
GPSA or OVA) inhibited early phase airway response
and Evans blue dye exudation. Therefore, this allergen-
unspecific inhibition of airway responses is thus not
likely related to allergen-IgE interaction but rather sug-
gests a mediator(s) mechanism.
Early phase airway response to allergen is closely related
to mediators such as histamine, cysLTs, and TXA2. How-
ever, our data reveal a histamine independency, since in
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pigs were stimulated in vitro with three different doses of AA. Arachidonic acid enhanced the production of cysLTs and TXB2 in airway tissue of
animals exposed to either PBS or low dose TMA-GPSA on five consecutive days in a dose dependent manner (Spearman Rank Correlation test
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Page 9 of 11the present study pretreatment with a H1 receptor antago-
nist showed no differences between groups. Thus, to
further elucidate the role of cysLTs and TXB2 in our gui-
nea pig model, we measured the levels of these mediators
in BAL fluid after allergen challenge. Our data show that
after repeated exposure to allergen, the levels of cysLTs
and TXB2 in the airways are significantly reduced. Thus,
this could at least in part be the explanation for the reduc-
tion of early phase airway response after repeated allergen
exposure.
In asthmatic patients, the concentrations of cysLTs and
TXA2 are increased in plasma, urine and BAL fluid during
asthma exacerbation and after experimental allergen chal-
lenges [8-11,31]. To investigate whether cysLTs and TXB2
work in same way in our guinea pig model as in humans,
we applied ICI 198,615 (a LT1 receptor antagonist) and
indomethacin (a non-specific COX inhibitor) to sensitized
guinea pigs before allergen challenge. A combined treat-
ment of ICI 198,615 and indomethacin attenuated early
phase airway response and plasma exudation in response
to TMA-GPSA challenge. This suggests an important role
of arachidonic acid metabolites in early phase airway
response to allergen challenge in guinea pigs, resembling
the acute allergic bronchoconstriction in humans [12,14].
To further understand whether the reduction of cysLTs
and TXB2 to repeated allergen challenge is due to a
decrease of the activity of 5-LO and COX2 pathways, we
measured the levels of these mediators in isolated airway
tissues from sensitized and repeatedly TMA-exposed gui-
nea pigs, in response to exogenously applied arachidonic
acid. The production of LTC4/D4/E4 and TXB2 in vitro
was significantly enhanced in the airways of repeatedly
TMA-exposed guinea pigs, consequently, suggesting an
up-regulation of 5-LO and COX pathways. Furthermore,
we found no reduction of LTC4/D4/E4 production in air-
way tissues incubated with a high dose of calcium iono-
phore. These data suggest that there is no reduction of
substrate for 5-LO after repeated allergen exposure. Taken
together, these data argue against a reduction in arachido-
nic acid mediator production via down-regulation of the
enzymes.
To further investigate the mechanism behind the
reduced production of cysLTs and TXB2 in airway after
repeated allergen exposure, we measured the activity of
protein tyrosine kinase Lyn, which is an intracellular sig-
naling molecule downstream FcεRI, and may regulate pro-
duction of cysLTs and TXB2. Allergen-induced
aggregation of FcεRI on mast cell activates tyrosine kinase
Lyn that binds to the FcεRIb-chain under resting condi-
tions [32]. Once activated, Lyn phosphorylates the tyrosine
residues in the FcεRIg-chain and recruits other signal
molecules and finally activates 5-LO and COX [16,17].
H o w e v e r ,i nt h ep r e s e n ts t u d yw ec o u l dn o tf i n da n y
deduction of Lyn activity after repeated allergen exposure
compared to PBS exposure, thus implicating the involve-
ment of other intracellular signaling molecules in regulat-
ing this response. One hypothesis that remains to be
investigated is that repeated allergen exposure may down-
regulate the expression of IgE-receptor and thus reduce
mast cell responsiveness in general, but solid techniques
to quantify guinea pig IgE-receptor are missing. Another
hypothesis might be an altered balance between the IgE-
receptor (FcεRI) and inhibitory receptors on mast cells,
such as FcgRII in response to repeated low dose allergen
exposure. Thus, studies in rodent mast cells suggest that
coligation of FcgRII with FcεRI results in a downregulation
of IgE-FcεRI mediated inflammatory mediator release [33].
Our current findings may have clinical implications.
Patients presenting recurrent and reversible airflow
obstruction but shows low or no response to allergen
challenge in laboratories may actually have an allergen
driven airway disease. Patients’ airway response to aller-
gen may have been down-regulated by repeated allergen
exposure, such as house-dust mite, animal dander or
some occupational allergen [34]. Thus, in a previous
clinical study, we have showed that repeated low dose
allergen exposure attenuates the late phase airway
response to allergen, despite existing bronchial hyperre-
sponsiveness [23]. This suggests that reduced allergic
response to allergen by repeated allergen exposure is
present not only in animal, but also in humans.
In summary, the current study indicates that in sensi-
tized guinea pigs, repeated exposure to allergen inhibits
allergen induced early phase airway response despite
existing non-specific bronchial hyperresponsiveness,
possible via reduced cysLTs and TXB2 production.
These findings might result from mast cells being less
responsive after repeated allergen exposure. Thus,
reduced production of cysLTs and TXB2 may reflect an
impaired intracellular mast cell signaling and could
explain the mechanisms of the reduced allergen induced
early phase airway response.
Abbreviations
EAR: Early asthmatic responses; AUC: Area under the curve.
Acknowledgements
This study was financially supported by the Swedish Heart and Lung
Foundation, the Swedish Environmental Work Fund, Herman Krefting
Foundation Against Asthma-Allergy, and the Vårdal Foundation. Dr. Hans
Welinder (Lund University, Lund, Sweden) kindly donated TMA-GPSA.
Author details
1Krefting Research Centre, Department of Internal Medicine and Clinical
nutrition, Institute of Medicine, University of Gothenburg, Gothenburg,
Sweden.
2Gilead Sciences, Inc., 199 East Blaine Street, Seattle, WA 98102,
USA.
Authors’ contributions
JL conceived and coordinated the study. ZHC and MS performed
experiment, analysis and interpretation of data. ZHC and MR wrote the
Cui et al. Clinical and Translational Allergy 2012, 2:7
http://www.ctajournal.com/content/2/1/7
Page 10 of 11manuscript with significant input from JL and MS. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 January 2012 Accepted: 22 March 2012
Published: 22 March 2012
References
1. Chung KF, Barnes PJ: Role of inflammatory mediators in asthma. Br Med
Bull 1992, 48:135-148.
2. Kleeberger SR, et al: Central role of cyclooxygenase in the response of
canine peripheral airways to antigen. J Appl Physiol 1986, 61:1309-1315.
3. Lotvall J, et al: A thromboxane mimetic, U-46619, produces plasma
exudation in airways of the guinea pig. J Appl Physiol 1992, 72:2415-2419.
4. Creticos PS, et al: Peptide leukotriene release after antigen challenge in
patients sensitive to ragweed. N Engl J Med 1984, 310:1626-1630.
5. Jakschik BA, Harrington LF, Malaviya R: Leukotriene formation by mouse
connective tissue mast cells. Eicosanoids 1992, 5:39-43.
6. Doran O, et al: Peptidoleukotriene (pLT) release from guinea pig lung
mast cells. Inflammation 1994, 18:89-97.
7. Ishida K, Thomson RJ, Schellenberg RR: Role of leukotrienes in airway
hyperresponsiveness in guinea-pigs. Br J Pharmacol 1993, 108:700-704.
8. Schwartzberg SB, Shelov SP, Van Praag D: Blood leukotriene levels during
the acute asthma attack in children. Prostaglandins Leukot Med 1987,
26:143-155.
9. Drazen JM, et al: Recovery of leukotriene E4 from the urine of patients
with airway obstruction. Am Rev Respir Dis 1992, 146:104-108.
10. Smith CM, et al: Urinary leukotriene E4 in bronchial asthma. Eur Respir J
1992, 5:693-699.
11. Bowton DL, et al: Phospholipase A2 and arachidonate increase in
bronchoalveolar lavage fluid after inhaled antigen challenge in
asthmatics. Am J Respir Crit Care Med 1997, 155:421-425.
12. Dahlen SE, et al: Leukotrienes are potent constrictors of human bronchi.
Nature 1980, 288:484-486.
13. Piper PJ, Samhoun MN: The mechanism of action of leukotrienes C4 and
D4 in guinea-pig isolated perfused lung and parenchymal strips of
guinea pig, rabbit and rat. Prostaglandins 1981, 21:793-803.
14. Weiss JW, et al: Bronchoconstrictor effects of leukotriene C in humans.
Science 1982, 216:196-198.
15. Peters-Golden M, Henderson WR Jr: Leukotrienes. N Engl J Med 2007,
357:1841-1854.
16. Wong WS, et al: Effects of tyrosine kinase inhibitors on antigen challenge
of guinea pig lung in vitro. J Pharmacol Exp Ther 1997, 283:131-137.
17. Costello PS, et al: Critical role for the tyrosine kinase Syk in signalling
through the high affinity IgE receptor of mast cells. Oncogene 1996,
13:2595-2605.
18. Gilfillan AM, Rivera J: The tyrosine kinase network regulating mast cell
activation. Immunol Rev 2009, 228:149-169.
19. Kinet JP, et al: IgE receptor (Fc epsilon RI) and signal transduction. Eur
Respir J 1996, 22(Suppl):116-118.
20. Ihre E, Zetterstrom O: Increase in non-specific bronchial responsiveness
after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993,
23:298-305.
21. Kageyama N, et al: Repeated allergen exposure enhances excitatory
nonadrenergic noncholinergic nerve-mediated bronchoconstriction in
sensitized guinea-pigs. Eur Respir J 1996, 9:1439-1444.
22. Cui ZH, et al: Bronchial hyperresponsiveness, epithelial damage, and
airway eosinophilia after single and repeated allergen exposure in a rat
model of anhydride-induced asthma. Allergy 1997, 52:739-746.
23. Palmqvist M, et al: Reduced late asthmatic response by repeated low-
dose allergen exposure. Eur Respir J 2001, 17:872-880.
24. Valstar DL, et al: Trimellitic anhydride-conjugated serum albumin
activates rat alveolar macrophages in vitro. J Occup Med Toxicol 2006,
1:13.
25. Rogers DF, Boschetto P, Barnes PJ: Plasma exudation. Correlation between
Evans blue dye and radiolabeled albumin in guinea pig airways in vivo.
J Pharmacol Methods 1989, 21:309-315.
26. Broekema M, et al: Persisting remodeling and less airway wall eosinophil
activation in complete remission of asthma. Am J Respir Crit Care Med
2011, 183:310-316.
27. Watson JW, et al: Multiple antigen challenge produces pulmonary
eosinophilia but not pulmonary hyperresponsiveness in actively
sensitized guinea pigs. Agents Actions 1992, 37:174-177.
28. Haczku A, et al: Effects of prolonged repeated exposure to ovalbumin in
sensitized brown Norway rats. Am J Respir Crit Care Med 1994, 150:23-27.
29. van Rensen EL, et al: Bronchial CD8 cell infiltrate and lung function
decline in asthma. Am J Respir Crit Care Med 2005, 172:837-841.
30. Gilfillan AM, Tkaczyk C: Integrated signalling pathways for mast-cell
activation. Nat Rev Immunol 2006, 6:218-230.
31. Matsuse H, et al: Naturally occurring parainfluenza virus 3 infection in
adults induces mild exacerbation of asthma associated with increased
sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol
2005, 138:267-272.
32. Kraft S, Kinet JP: New developments in FcepsilonRI regulation, function
and inhibition. Nat Rev Immunol 2007, 7:365-378.
33. Daeron M, Vivier E: Biology of immunoreceptor tyrosine-based inhibition
motif-bearing molecules. Curr Top Microbiol Immunol 1999, 244:1-12.
34. Plaschke P, et al: Adult asthmatics sensitized to cats and dogs:
symptoms, severity, and bronchial hyperresponsiveness in patients with
furred animals at home and patients without these animals. Allergy 1999,
54:843-850.
doi:10.1186/2045-7022-2-7
Cite this article as: Cui et al.: Repeated allergen exposure reduce early
phase airway response and leukotriene release despite upregulation of
5-lipoxygenase pathways. Clinical and Translational Allergy 2012 2:7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cui et al. Clinical and Translational Allergy 2012, 2:7
http://www.ctajournal.com/content/2/1/7
Page 11 of 11